S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
Free Trial

PMV Pharmaceuticals (PMVP) Insider Trading & Ownership

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)
Free pmvp Stock Alerts
$1.60
-0.04 (-2.45%)
(As of 01:43 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

PMV Pharmaceuticals (NASDAQ:PMVP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$222,931.26
Get PMVP Insider Trade Alerts

Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PMVP Insider Buying and Selling by Quarter

Ad Manward Press
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
We explain how this event works in full right here.

PMV Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2023Orbimed Advisors LlcMajor ShareholderSell87,786$2.23$195,762.78  
9/15/2023Deepika JalotaInsiderSell4,104$6.62$27,168.48  
(Data available from 1/1/2013 forward)

PMVP Insider Trading Activity - Frequently Asked Questions

Who is on PMV Pharmaceuticals's Insider Roster?

The list of insiders at PMV Pharmaceuticals includes Arnold J Levine, David Henry Mack, Deepika Jalota, Euclidean Capital Llc, Leila Alland, Orbimed Advisors Llc, Richard A Heyman, Thilo Schroeder, and Winston Kung. Learn more on insiders at PMVP.

What percentage of PMV Pharmaceuticals stock is owned by insiders?

7.60% of PMV Pharmaceuticals stock is owned by insiders. Learn more on PMVP's insider holdings.

Which PMV Pharmaceuticals insiders have been selling company stock?

The following insiders have sold PMVP shares in the last 24 months: Deepika Jalota ($27,168.48), and Orbimed Advisors Llc ($613,973.07).

How much insider selling is happening at PMV Pharmaceuticals?

Insiders have sold a total of 118,143 PMV Pharmaceuticals shares in the last 24 months for a total of $641,141.55 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:PMVP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press